FDA rejects migraine treatment made by North Carolina firm

A biopharmaceutical company with operations in the Triangle is facing a regulatory setback.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 22, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news